Literature DB >> 8359797

Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis.

Y Nakanuma1.   

Abstract

Primary biliary cirrhosis is characterized by the immune-mediated, nonsuppurative destruction of intrahepatic small bile ducts, with significant T-cell involvement. To date, B cells in livers of primary biliary cirrhosis patients have been ignored in immunopathological evaluations of nonsuppurative cholangitis. This study aimed to correlate the distribution of activated T and B cells with the histopathology of nonsuppurative cholangitis in primary biliary cirrhosis, with emphasis on B cell infiltration. The distribution of activated T and B cells and the histopathology in primary biliary cirrhosis were heterogeneous in bile ducts showing nonsuppurative cholangitis; they were also heterogeneous in various parts of a given bile duct. Although activated T cells were significantly involved in the occurrence of nonsuppurative cholangitis, B cell-predominant reaction or cholangitis and B-cell infiltration into the biliary epithelial layer were also prominent in some nonsuppurative cholangitis. Many bile ducts with nonsuppurative cholangitis of various histological types showed intermixed activated T- and B-cell infiltration. These findings indicate that immune mechanism(s) involving B cells and, probably, humoral immunity are at work in the occurrence of nonsuppurative cholangitis and the destruction of bile ducts in primary biliary cirrhosis. Cell-to-cell interactions of activated T and B cells should therefore be evaluated in livers of patients with primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359797

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

2.  B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Authors:  Yuki Moritoki; Zhe-Xiong Lian; Keith Lindor; Joseph Tuscano; Koichi Tsuneyama; Weici Zhang; Yoshiyuki Ueno; Robert Dunn; Marilyn Kehry; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

3.  Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.

Authors:  Qinglong Jin; Yuki Moritoki; Ana Lleo; Koichi Tsuneyama; Pietro Invernizzi; Hitoshi Moritoki; Kentaro Kikuchi; Zhe-Xiong Lian; Gideon M Hirschfield; Aftab A Ansari; Ross L Coppel; M Eric Gershwin; Junqi Niu
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

4.  B cell depletion in treating primary biliary cirrhosis: pros and cons.

Authors:  Yu-Feng Yin; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

5.  Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis.

Authors:  F Hua; L Wang; X Rong; Y Hu; J M Zhang; W He; F C Zhang
Journal:  Clin Exp Immunol       Date:  2016-09-09       Impact factor: 4.330

6.  Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis.

Authors:  Yichen Han; Zhen-Hua Bian; Si-Yu Yang; Cheng-Bo Wang; Liang Li; Yan-Qing Yang; Aftab A Ansari; M Eric Gershwin; Xiaofeng Zeng; Zhe-Xiong Lian; Zhi-Bin Zhao
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

7.  HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.

Authors:  S Shimoda; M Nakamura; H Ishibashi; K Hayashida; Y Niho
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

8.  Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.

Authors:  Yuki Moritoki; Koichi Tsuneyama; Yuka Nakamura; Kentaro Kikuchi; Akira Shiota; Yoshiyuki Ohsugi; Zhe-Xiong Lian; Weici Zhang; Guo-Xiang Yang; Shigeharu Ueki; Masahide Takeda; Ayumi Omokawa; Tomoo Saga; Akiko Saga; Daisuke Watanabe; Masahito Miura; Yoshiyuki Ueno; Patrick S C Leung; Atsushi Tanaka; M Eric Gershwin; Makoto Hirokawa
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.